Investing.com
Morgan Stanley cuts Amicus Therapeutics target to $19 from $20 By Investing.com
On Thursday, Morgan Stanley (NYSE:MS) adjusted its outlook on Amicus (NASDAQ:FOLD) Therapeutics (NASDAQ:FOLD), reducing the price target to $19 from the previous $20. Despite the price target ...
3 hours ago